Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.4630
-0.0270 (-5.51%)
Jul 14, 2025, 4:00 PM - Market closed
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.23 million as of July 14, 2025. Its market cap has decreased by -50.51% in one year.
Market Cap
2.23M
Enterprise Value
3.11M
1-Year Change
-50.51%
Ranking
Category
Stock Price
0.46
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.23M, a decrease of -95.47%. That is a compound annual growth rate of -29.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 2.30M | -23.33% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |